Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 9/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | NSD2 | O96028 | 1/20 | 0.50 |
| ▸ | ABL1 | P00519 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.50 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28330023 | 0.86 | ALOX5 (0.54) | ALOX5MAOBLMNACYP1A2PTGS1 | |
| SCHEMBL694957 | 0.85 | S1PR1 (0.54) | ALOX5MAOBLMNACYP1A2PTGS1 | |
| SCHEMBL696437 | 0.85 | ALOX5 (0.53) | ALOX5MAOBLMNACYP1A2PTGS1 | |
| SCHEMBL3775086 | 0.85 | ALOX5 (0.53) | ALOX5MAOBLMNACYP1A2PTGS1 | |
| SCHEMBL696249 | 0.85 | S1PR1 (0.54) | ALOX5MAOBLMNACYP1A2PTGS1 | |
| SCHEMBL3219429 | 0.82 | MAOB (0.55) | ALOX5MAOBLMNAL3MBTL1MAPT | |
| SCHEMBL694270 | 0.81 | AR (0.51) | ALOX5MAOBLMNACYP1A2PTGS1 | |
| SCHEMBL8761070 | 0.79 | ALOX5 (0.58) | ALOX5MAOBLMNACYP1A2PTGS1 | |
| SCHEMBL80829 | 0.78 | MAOB (0.68) | ALOX5MAOBMAOALCK | |
| SCHEMBL29411728 | 0.78 | MAOB (0.68) | ALOX5MAOBMAOALCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11590084-B2 | Microcapsules for controlled delivery of an active pharmaceutical ingredient | BIELSKI ROMAN (US) | 2023-02-28 | — | — | US | disclosed |
| US-20190125687-A1 | Microcapsules for Controlled Delivery of an Active Pharmaceutical Ingredient | BIELSKI ROMAN (US) | 2019-05-02 | — | — | US | disclosed |
| WO-2017192407-A1 | MICROCAPSULES FOR CONTROLLED DELIVERY OF AN ACTIVE PHARMACEUTICAL INGREDIENT | BIELSKI ROMAN (US) | 2017-11-09 | — | — | WO | disclosed |
| US-5698580-A | TREATING DISEASES CAUSED BY RESPIRATORY SYNCYTIAL VIRUS | RATIONAL DRUG DESIGN LABORATORIES (JP) | 1997-12-16 | — | — | US | disclosed |
| EP-0770609-A1 | ANTIVIRAL AGENT CONTAINING BENZODITHIIN DERIVATIVE AS ACTIVE INGREDIENT | Rational Drug Design Laboratories (JP) | 1997-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190125687-A1 | Microcapsules for Controlled Delivery of an Active Pharmaceutical Ingredient | PUF60, SRM, SMS | ALOX5 481/4885MAOB 305/4885LMNA 701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.